Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 7, 2026; 32(37): 120885
Published online Oct 7, 2026. doi: 10.3748/wjg.120885
Published online Oct 7, 2026. doi: 10.3748/wjg.120885
Figure 6 Portulaca oleracea L.
-derived exosome-like nanoparticles alleviate colitis in fecal microbiota transplantation mice. A: Schematic diagram of the experimental timeline; B: Body weight changes of mice; C: Disease activity index scores; D: Colon length; E: Fecal occult blood test results on day 24; F: Body weight on day 24; G: Colon length on day 24; H: Hematoxylin & eosin staining (× 50, × 100); I: Ultrastructure of tight junctions and endoplasmic reticulum in intestinal epithelial cells observed by transmission electron microscopy (× 6000, × 8200); J: Representative immunofluorescence images of Bip (red), ZO-1 (green), and DAPI (blue) in mouse colon tissues (× 200); K: Quantitative analysis of the relative fluorescence intensity of Bip and ZO-1 in mouse colon tissues. aP < 0.05, cP < 0.001, dP < 0.0001. NS: Not significant; DSS: Dextran sulfate sodium; FMT: Fecal microbiota transplantation; PELNs: Portulaca oleracea L.-derived exosome-like nanoparticles.
- Citation: Liu XY, Liu ZX, Tan WW, Zhang WB, Qiao D, Chen SH, Zhang YL, Zheng L, Ge WS, Dai YC. Portulaca oleracea L.-derived exosome-like nanoparticles ameliorate colitis by modulating gut microbiota and metabolites to reduce endoplasmic reticulum stress. World J Gastroenterol 2026; 32(37): 120885
- URL: https://www.wjgnet.com/1007-9327/full/v32/i37/120885.htm
- DOI: https://dx.doi.org/10.3748/wjg.120885